Lord, Abbett & Co
PLSE icon

Lord, Abbett & Co’s Pulse Biosciences PLSE Stock Holding History

Lord, Abbett & Co’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8.61M Buy
+172,458
New +$7.28M 0.03% 413

Other funds holding PLSE

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return
Griffin Asset Management
Griffin Asset Management New York $934M AUM 18.69% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Lord, Abbett & Co's PLSE Position: Q3 2026 in Review

Lord, Abbett & Co opened a new position in Pulse Biosciences (PLSE) in Q3 2026: 172,458 shares worth $8.61M. The stake represents 0.03% of the portfolio and ranks #413 among its holdings.

86 funds tracked by Wall St. Rank hold PLSE as of Q3 2026.

  • Lord, Abbett & Co held 172,458 shares of Pulse Biosciences worth $8.61M as of Q3 2026.
  • Pulse Biosciences was a new Lord, Abbett & Co position in Q3 2026.
  • Pulse Biosciences made up 0.03% of Lord, Abbett & Co's portfolio in Q3 2026, its #413 holding.
  • 86 funds tracked by Wall St. Rank held Pulse Biosciences as of Q3 2026.

Based on Lord, Abbett & Co's 13F filing for Q3 2026, filed 13 Nov 2026.